Clinical trial NCT06218615: Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement
Official title: Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cancer
Lead sponsor: Fred Hutchinson Cancer Center
Sponsor class: OTHER
First posted: 2024-01-23
Enrollment: 109
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: Under-representation of patients from racial/ethnic minority groups in cancer clinical trials is a major barrier to health equity. Black patients are significantly less likely to be enrolled in clinical trials compared with non-Hispanic White (White) patients although they carry a disproportionate burden of cancer mortality, the shortest survival rates, and are more likely to be diagnosed at later stages. Further, medical mistrust and lack of awareness and complexity of clinical trials are barriers that reduce the likelihood of clinical trial participation. The objective of this pilot study is to understand the effect of a culturally tailored decision aid (previously developed by our research team) on 1) medical mistrust, 2) patient knowledge about clinical trials, and 3) decision-making self-efficacy and determine the acceptability of the decision aid among Black patients currently or ever been diagnosed with cancer.

Detailed description: This study will be conducted online through Qualtrics.

Participants will answer pre-test survey questions, watch the culturally tailored decision aid video \[Fostering Opportunities in Research Using Marketing Strategies (FOR US)\] intervention, then answer post-intervention survey questions.

Eligibility criteria: Inclusion Criteria:

* Are 18 years of age or older
* Identify as Black/African- American
* Have Current or previous diagnosis of cancer
* Speak and understand English

Exclusion Criteria:

* Are younger than 18 years of age
* Do not identify as Black/African- American
* Do not have a current or previous diagnosis of cancer
* Are non - English-speaking

Primary outcomes:
measure: Change in Medical Mistrust from Baseline to Post-Intervention: 12-item Group-Based Medical Mistrust Scale
timeFrame: Baseline and post-intervention (up to 15 minutes)
measure: Change in Trust in Health Information from Baseline to Post-Intervention: Health Information National Trends Survey (HINTS)
timeFrame: Baseline and post-intervention (up to 15 minutes)
measure: Change in Patient Knowledge from Baseline to Post-Intervention: Five unique question items
timeFrame: Baseline and post-intervention (up to 15 minutes)
measure: Change in Clinical Trial Participation Decision-Making Self-Efficacy from Baseline to Post-Intervention: 11-item Decision Self-Efficacy Scale
timeFrame: Baseline and post-intervention (up to 15 minutes)
measure: Acceptability of the intervention
timeFrame: At post-intervention (up to 15 minutes)
Secondary outcomes:
Other outcomes:
Locations:
city: Seattle
country: United States
facility: Fred Hutch/University of Washington Cancer Consortium
state: Washington
Study officials:
affiliation: Fred Hutch/University of Washington Cancer Consortium
name: Vida Henderson
role: PRINCIPAL_INVESTIGATOR
References: